Niikura, R., Hayakawa, Y., Hirata, Y., et al. (2018) Long-Term Proton Pump Inhibitor Use Is a Risk Factor of Gastric Cancer after Treatment for Helicobacter pylori: Retrospective Cohort Analysis. Gut, 67, 1908-1910. https://doi.org/10.1136/gutjnl-2017-315710

has been cited by the following article:

• TITLE: Does the Location and Prevelance of Gastric Intestinal Metaplasia Change in Patients with Functional Dyspepsia

  AUTHORS: Tahir Buran, Elmas Kasap, Semin Ayhan

  KEYWORDS: Gastric Intestinal Metaplasia, Helicobacter Pylori, Gastritis, Functional Dispepsia

  JOURNAL NAME: Open Access Library Journal, Vol.8 No.12, December 15, 2021

  ABSTRACT: Gastric intestinal metaplasia plays a significant role in the pathogenesis of intestinal gastric cancer. Objective: A retrospective analysis of demographic characteristics, site of involvement, and incidence was performed involving patients who underwent endoscopy who had biopsy-diagnosed intestinal metaplasia. Materials and Methods: The study included 720 patients with functional dyspepsia retrospectively from among 6160 patients who underwent upper endoscopy in Celal Bayar University, Faculty of Medicine, Gastroenterology Department, between 2014 and 2020. Results: Intestinal metaplasia was detected at the antrum, corpus, and angulus in 59.94%, 13.47%, and 28.57% of the cases, respectively. Antral lesions were significantly more prevalent (P